Sovi.AI - AI Math Tutor

Scan to solve math questions

QUESTION IMAGE

question 40 when the fda identifies a medication that creates a risk of…

Question

question 40

when the fda identifies a medication that creates a risk of illness, injury, or gross deception, which of the following options can the fda use for product removal?

  • develop commercials for the public to build awareness.
  • seek the legal authority to stop distribution.
  • add the medication to the controlled substance schedule.
  • request that the manufacturer submit a new medication application.

Explanation:

Analyze the FDA's role in product removal

Using the FDA Regulations knowledge point
The Food and Drug Administration (FDA) is responsible for protecting public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices. When a medication on the market is identified as posing a risk of illness, injury, or gross deception, the FDA must take action to remove the product from the market or halt its distribution.

Evaluate the legal mechanisms for distribution halt

Under federal law, if a manufacturer refuses to voluntarily recall a dangerous or deceptive drug product, the FDA can seek legal authority (such as a court injunction, seizure, or administrative order depending on the specific product class) to legally stop the distribution and sale of the product.

Assess the incorrect options

  • Developing commercials is an educational campaign, not a legal mechanism for product removal.
  • Scheduling a drug under the Controlled Substances Act is the authority of the DEA, not a standard mechanism for removing a defective or dangerous product from the market.
  • Requesting a new medication application (NDA) is for approving new drugs, not for removing an existing hazardous product.

Answer:

  • (A) Develop commercials for the public to build awareness.
  • (B) Seek the legal authority to stop distribution. (Correct answer)
  • (C) Add the medication to the controlled substance schedule.
  • (D) Request that the manufacturer submit a new medication application.